Story display


ID:

671

Date:

2012-02-19

Headline:

Treating Depression: Is there a placebo effect?

Reporter's name:

Lesley Stahl

Delay/denial:

No

Lawsuit:

No

Fees:

No

Media outlet:

CBS News

City:

Cambridge, MA

Summary:

According to research by a Harvard psychologist, anti-depressants such as Zoloft and Prozac are no more effective than a placebo for many people – and the Food and Drug Administration allowed unrepresentative studies to influence the approval process. (Watch the video report at http://www.cbsnews.com/video/watch/?id=7399362n)

Notes:

Irving Kirsch, associate director of the Placebo Studies Program at Harvard Medical School, used FOIA to obtain records of drug-company studies of anti-depressant medications which had not been published – and showed the medication’s effects were less pronounced than drugmakers insisted.

Keywords:

antidepressant, depression, medication, pharmaceutical, Prozac, Zoloft, placebo, Food & Drug Administration, FDA, Irving Kirsch, Harvard Medical School, Placebo Studies Program, psychiatry, Eli Lilly

Impact:

Kirsch’s research, and the “60 Minutes” report, inspired a California woman to sue Pfizer over the failure of its anti-depressant, Zoloft, to treat her depression, despite three years of usage as prescribed (See “Pfizer disputes claim against antidepressant,” The Associated Press, 1/31/13, http://www.usatoday.com/story/news/nation/2013/01/31/pfizer-zoloft-lawsuit/1881441/).

URL:

http://www.cbsnews.com/2102-18560_162-57380893.html


Agencies:

FDA

States:

MA

Categories:

business
drug safety
health care


Return to front page